|
AKTX | Akari Therapeutics Plc |
|
|
AKTX | Akari Therapeutics Plc |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.00 |
| Leverage | 51.86% |
| Market Cap | $ 9.2B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -30.9m |
| Margin | 1707.65% |
None